Hjem › Hjernetumorer › Ohio › Columbus
Hjernetumorer kliniske forsøg i Columbus, OH
11 studier for Hjernetumorer søger deltagere på steder i og omkring Columbus (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RekruttererFase 2
- Ohio State University, Columbus
SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases
RekruttererFase 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
RekruttererFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- og 15 flere
Targeted Pediatric High-Grade Glioma Therapy
RekruttererObservationsstudie
- Nationwide Children's Hospital, Columbus
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
RekruttererFase 2
- The Ohio State University College of Medicine (OSUCOM), Columbus
Study of Olutasidenib and Temozolomide in HGG
RekruttererFase 2
- Nationwide Children's Hospital, Columbus
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
RekruttererFase 2
- Nationwide Children's Hospital, Columbus
Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
RekruttererFase 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RekruttererFase 2
- Nationwide Children's Hospital, Columbus
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RekruttererFase 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements
RekruttererFase 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
Hjernetumorer forsøg i andre byer
- Houston, TX35 studier
- Boston, MA28 studier
- New York City, NY25 studier
- Washington, DC20 studier
- Los Angeles, CA16 studier
- Miami, FL15 studier
- Durham, NC14 studier
- St. Louis, MO12 studier
- Cleveland, OH11 studier
- Seattle, WA11 studier
- Rochester, MN11 studier
- Baltimore, MD11 studier
Andre studier i Columbus
- Ikke-småcellet lungecancer56 studier
- Brystkræft39 studier
- Ægstockræft39 studier
- Kræft (alle typer)38 studier
- Lungecancer37 studier
- Akut myeloid leukæmi35 studier
- Kronisk lymfatisk leukæmi28 studier
- Metastatisk cancer27 studier
- Livmoderslimhindekræft25 studier
- Colorektal kræft24 studier
- Prostatakræft24 studier
- Multipelt myelom24 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.